Table 1 Median age and % Metastatic disease at presentation of SCCO, SCCO-HT, NET-O, and SCLC
From: Genomic alterations in neuroendocrine cancers of the ovary
Small Cell Cancer Type | Median Age | %Metastatic |
|---|---|---|
SCCO (n = 10) | 42 (12–75) | 70 % |
SCCO-HT (n = 18) | 26 (8–40) | 50 % |
NET-O (n = 18) | 62 (13–76) | 33 % |
SCLC (n = 58) | 66 (36–86) | 65 % |